$2.23 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 64 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 26.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Sell | BIOGEN IDEC INC | $149,164,000 | -12.3% | 439,428 | -14.6% | 6.69% | -6.6% |
| AMGN | Sell | AMGEN INC | $142,481,000 | -13.8% | 894,473 | -24.0% | 6.39% | -8.1% |
| CELG | Sell | CELGENE CORP | $126,878,000 | -1.9% | 1,134,258 | -16.9% | 5.69% | +4.5% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $113,293,000 | +13.9% | 1,253,243 | -9.1% | 5.08% | +21.3% |
| INCY | Sell | INCYTE CORPORATION | $97,442,000 | +21.7% | 1,332,814 | -18.3% | 4.37% | +29.8% |
| MYL | Sell | MYLAN INC | $85,647,000 | -12.8% | 1,519,368 | -29.7% | 3.84% | -7.1% |
| TEVA | Sell | TEVA PHARMACEUTICALadr | $79,415,000 | -13.5% | 1,380,888 | -19.2% | 3.56% | -7.8% |
| REGN | Sell | REGENERON PHARMCEUTICALS | $76,177,000 | -7.2% | 185,685 | -18.5% | 3.42% | -1.1% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $71,352,000 | -11.7% | 385,624 | -20.9% | 3.20% | -5.9% |
| B108PS | Sell | ACTAVIS PLCshares | $66,116,000 | -21.2% | 256,850 | -26.2% | 2.97% | -16.0% |
| TMO | Sell | THERMO FISHER SCIENTIFIC | $65,237,000 | +2.2% | 520,686 | -0.7% | 2.93% | +8.9% |
| GILD | Sell | GILEAD SCIENCES INC | $64,503,000 | -53.7% | 684,307 | -47.8% | 2.89% | -50.7% |
| PTCT | Sell | PTC THERAPEUTICS I | $58,766,000 | +1.0% | 1,135,130 | -14.2% | 2.64% | +7.6% |
| P103PS | Sell | NPS PHARMACEUTICALS | $58,057,000 | +29.3% | 1,623,073 | -6.0% | 2.60% | +37.9% |
| KERX | Sell | KERYX BIOPHARMACEUTICALS | $46,092,000 | -7.3% | 3,257,358 | -9.9% | 2.07% | -1.2% |
| MNKKQ | Sell | MALLINCKRODT PLCshares | $39,678,000 | -26.7% | 400,664 | -33.3% | 1.78% | -21.9% |
| PRGO | Sell | PERRIGO COshares | $38,792,000 | -29.7% | 232,068 | -36.9% | 1.74% | -25.1% |
| HALO | Sell | HALOZYME THERAPEUTICS | $35,940,000 | -13.4% | 3,724,351 | -18.3% | 1.61% | -7.7% |
| OMED | Sell | ONCOMED PHARMACEUTICALS | $34,779,000 | +8.4% | 1,598,293 | -5.7% | 1.56% | +15.6% |
| AGN | Sell | ALLERGAN INC | $34,599,000 | -29.0% | 162,750 | -40.5% | 1.55% | -24.4% |
| GEVA | Sell | SYNAGEVA BIOPHARMA | $33,765,000 | -18.5% | 363,884 | -39.6% | 1.52% | -13.1% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS | $31,729,000 | -11.1% | 1,120,379 | -20.7% | 1.42% | -5.3% |
| XLRN | Sell | ACCELERON PHARMA | $27,817,000 | +26.6% | 713,995 | -1.7% | 1.25% | +35.1% |
| VRTX | Sell | VERTEX PHARMACEUTICALS | $25,215,000 | -31.9% | 212,250 | -35.7% | 1.13% | -27.5% |
| UTHR | Sell | UNITED THERAPEUTICS | $21,091,000 | -10.1% | 162,880 | -10.7% | 0.95% | -4.3% |
| SGNT | Sell | SAGENT PHARMACEUTICALS | $20,938,000 | -34.6% | 833,861 | -19.0% | 0.94% | -30.3% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $18,204,000 | +5.2% | 34,416 | -8.2% | 0.82% | +12.2% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS | $17,574,000 | -27.4% | 1,459,603 | -31.6% | 0.79% | -22.7% |
| AKRXQ | Sell | AKORN INC | $15,723,000 | -25.9% | 434,343 | -25.7% | 0.70% | -21.0% |
| NXTM | Sell | NXSTAGE MEDICAL | $14,470,000 | +25.0% | 807,012 | -8.5% | 0.65% | +33.3% |
| INGN | Sell | INOGEN INC | $6,485,000 | +25.1% | 206,734 | -17.8% | 0.29% | +33.5% |
| IMDZ | Sell | IMMUNE DESIGN CORP | $652,000 | -61.1% | 21,181 | -77.7% | 0.03% | -59.2% |
| VRX | Sell | VALEANT PHARMACEUTICALS INTL | $258,000 | -97.9% | 1,800 | -98.1% | 0.01% | -97.7% |
| ANTH | Exit | ANTHERA PHARMACEUT | $0 | – | -247,961 | -100.0% | -0.02% | – |
| PRQR | Exit | PROQR THRAPEUTICS | $0 | – | -70,000 | -100.0% | -0.05% | – |
| AMBI | Exit | AMBIT BIOSCIENCES | $0 | – | -146,111 | -100.0% | -0.10% | – |
| CI | Exit | CIGNA CORP | $0 | – | -103,164 | -100.0% | -0.39% | – |
| TRNX | Exit | TORNIER N V | $0 | – | -469,023 | -100.0% | -0.47% | – |
| BSX | Exit | BOSTON SCIENTIFIC | $0 | – | -1,047,166 | -100.0% | -0.52% | – |
| THRX | Exit | THERAVANCE INC | $0 | – | -971,438 | -100.0% | -0.70% | – |
| F113PS | Exit | COVIDIEN PLC | $0 | – | -232,358 | -100.0% | -0.85% | – |
| INSM | Exit | INSMED INC | $0 | – | -1,625,323 | -100.0% | -0.89% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -842,149 | -100.0% | -0.98% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -2,269,597 | -100.0% | -1.01% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -444,107 | -100.0% | -1.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 45 | Q2 2024 | 6.7% |
| DR REDDYS LABS LTD | 45 | Q2 2024 | 2.0% |
| PTC THERAPEUTICS INC | 43 | Q2 2024 | 2.7% |
| GILEAD SCIENCES INC | 41 | Q2 2024 | 8.4% |
| VERTEX PHARMACEUTICL | 41 | Q2 2024 | 6.0% |
| INCYTE CORPORATION | 41 | Q2 2024 | 5.2% |
| AMICUS THERAPEUTICS INC | 40 | Q2 2024 | 6.6% |
| PFIZER INC | 38 | Q2 2024 | 6.3% |
| MERCK & CO. INC | 37 | Q2 2024 | 6.4% |
| MEDTRONIC PLC | 36 | Q2 2024 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | February 14, 2024 | 2,382,644 | 3.7% |
| Galera Therapeutics, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-13 |
| N-PX | 2024-08-09 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.